患者对先发制药基因组学结果的理解
Joel E Pacyna1, Suzette J Bielinski2, Janet E Olson2
1Biomedical Ethics Research Program, Mayo Clinic, Rochester, MN, USA.
Pharmacogenomics
|September 25, 2025
概括
预防性药物基因组 (PGx) 测试可能会提高药物安全性,但使用现有处方的患者难以理解结果. 在收到PGx信息后,对当前药物的信心下降,突出显示需要更好的患者支持.
科学领域:
- 药物基因组学 药物基因组学
- 临床药房 临床药房
- 患者的治疗结果.
背景情况:
- 预防性药物基因组 (PGx) 测试显示了提高药物安全性和有效性的前景.
- 关于患者如何解释预先生成的PGx信息的理解有限.
研究的目的:
- 评估患者在预防性PGx测试后对他们的处方的理解和信心.
- 确定影响患者处理PGx结果的因素,在初级保健环境中.
主要方法:
- 一项调查研究涉及5000名在美国一家初级保健诊所接受预防性PGx测试的人.
- 评估患者对PGx结果的理解和对当前药物的信心,测试前和测试后.
主要成果:
- 超过3,400名参与者完成了结果前和后的调查.
- 目前处方的患者更有可能报告难以理解PGx结果.
- 在测试后,对当前药物方案和剂量的信心下降,这与处方数和结果理解有关.
结论:
- 在初级保健中实施预防性PGx测试需要制定支持现有处方患者的策略.
- 确保患者了解PGx结果的相关性和可操作性对于有效融入医疗保健至关重要.
相关概念视频
Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Pharmacokinetics: Overview
9.1K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.1K
Pharmacodynamics: Overview and Principles
2.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.8K
Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Factors Affecting Drug Response: Overview
3.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.0K
Dosage Regimens: Partial Pharmacokinetic Parameters
154
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
154


